Laura P. James
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Director, Translational Research Institute
Also affiliated: Northwestern University (2018); Twitter (United States) (1999); University of North Carolina at Chapel Hill (2017); Tufts University (2017); American Heart Association (2011); Cincinnati Children's Hospital Medical Center (2005); Fera Science (United Kingdom) (2003); Boston Children's Hospital (2006); Arkansas Children's Hospital (1995–2024); Translational Research Institute (2018); University Hospitals Birmingham NHS Foundation Trust (2023); Primary Children's Hospital (2008); Children's Mercy Hospital (1998–2003); University of Louisville (2001); University of Kansas (2003); University of Pittsburgh (1998); Iowa State University (2025); University of California, San Francisco (2009); East Carolina University (2018); Medical College of Wisconsin (2009–2010); University of Cambridge (2022); University of Michigan (2012–2015); University of Arkansas Medical Center (2002–2016); Society of Toxicology (1999); Nuffield Orthopaedic Centre (2025); Children's of Alabama (1995–1996); University of Alabama at Birmingham (1995–1996); University of California San Diego (2000–2009); University of Oxford (2025); Rady Children's Hospital-San Diego (2000); Cayman Chemical (United States) (2012); National Institute of Child Health (2000); Arkansas Cardiology (2012); May Institute (2000); American Association for Dental Research (2000); Institute for Diabetes Discovery (2017); VA Ann Arbor Healthcare System (2015); Potato Research Institute (2011); Kosair Children's Hospital (2001); Universitätsklinikum Aachen (2015); Taunton & Somerset NHS Foundation Trust (2022); Mercy Hospital (2000); Children's Hospital of Pittsburgh (1998); The Christie Hospital (2004); Arkansas State Crime Laboratory (2011–2012); National Institute of Child Health (2000); Pediatrics and Genetics (2006–2021); Institute of Molecular Biology and Biophysics (2010); Rainbow Babies & Children's Hospital (2000); Eisai (United States) (2005); Arkansas Department of Agriculture (2003–2025); Health and Human Development (2HD) Research Network (2000–2001); Arkansas Department of Health (2011–2012); Institute of Pharmacology (2007–2009); University of Salford (2021); Case Western Reserve University (2000); University of Cincinnati (2010); University at Buffalo, State University of New York (2007); Washington State University (2017); University of Missouri–Kansas City (1998–2004); University of Birmingham (2022–2024); The University of Texas Southwestern Medical Center (2009); Michigan State University (2015)
Faculty Researcher
Upstream record may be merged OpenAlex, the source of these figures, lists 66 institutions in 9 countries for this author record — a pattern that usually means it combines several researchers with similar names. The totals above may include work by other people.
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Laura P. James' research focuses on understanding and mitigating the impacts of various health conditions, with a particular emphasis on liver injury and infectious diseases. She has investigated the short-term safety of repeated acetaminophen use in patients with compensated cirrhosis and explored how exogenous phosphatidic acid can reduce acetaminophen-induced liver injury in mice. Her work also extends to the study of hepatic metabolism, examining the roles of pyruvate and alanine in maintaining antioxidant capacity and resistance to oxidative insult.
In the realm of infectious diseases, James has contributed to research on SARS-CoV-2, including studies on pediatric seroprevalence in Arkansas and the genomic epidemiology of the virus in a UK university setting. Her research portfolio also includes reviews of photovoice projects with youth and experiences of pregnant mothers during the COVID-19 lockdown. She serves as Director of the Translational Research Institute at the University of Arkansas for Medical Sciences and has a substantial publication record, evidenced by her h-index of 52 and over 10,000 citations. Her collaborative network includes Joshua L. Kennedy, Jessica Snowden, Jeffery H. Moran, and Karl W. Boehme, with whom she shares multiple publications.
Metrics
- h-index: 52
- Publications: 286
- Citations: 10,629
Selected Publications
-
NAPQI is absent in the mouse brain after sub-hepatotoxic and hepatotoxic doses of acetaminophen (2025)
-
Vaccine hesitancy or hesitancies? A latent class analysis of pediatric patients' parents (2025)
-
Development of clinical assays for determination of acetaminophen protein adducts (2024)
-
Differentiating Ischemic Hepatitis from Acetaminophen Overdose in Acute Liver Failure: Role of Acetaminophen Adducts—Ischemic Hepatitis vs Acetaminophen Overdose (2024)
-
Association of Acetaminophen (Paracetamol) Use With Severity and Outcomes in Patients With Viral Hepatitis-Associated Acute Liver Failure (2024)
-
Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of <scp>CYP2C19</scp> genetic variation and obesity in the pediatric population (2024)
-
115 Strategies for Training and Advancing under-represented Researchers (STARs) (2024)
-
Scientia pro bono humani generis: Science for the benefit of humanity (2024)
-
Vitamin D Oral Replacement in Children With Obesity Related Asthma: <scp>VDORA1</scp> Randomized Clinical Trial (2023)
-
Hepatic pyruvate and alanine metabolism are critical and complementary for maintenance of antioxidant capacity and resistance to oxidative insult (2023)
-
Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations (2023)
-
Pharmacokinetics of Oral Vitamin D in Children with Obesity and Asthma (2023)
-
A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas University (2023)
-
Development of a clinical and translational research curriculum for undergraduate students (2023)
-
235 Use of Community Review Boards to Evaluate the Utility of the ICF Navigator - A Browser-based Tool to Create Plain-Language Informed Consent Forms (2023)
Collaboration Network
Top Collaborators
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Vitamin D Oral Replacement in Children With Obesity Related Asthma: <scp>VDORA1</scp> Randomized Clinical Trial
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Pharmacokinetics of Oral Vitamin D in Children with Obesity and Asthma
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
Showing 5 of 9 shared publications
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Modifying laboratory testing via home brew during the COVID-19 pandemic
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
Showing 5 of 7 shared publications
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Rural Research Network to engage rural and minority community members in translational research
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
Showing 5 of 7 shared publications
- Hepatic pyruvate and alanine metabolism are critical and complementary for maintenance of antioxidant capacity and resistance to oxidative insult
- Short‐Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis
- Exogenous phosphatidic acid reduces acetaminophen-induced liver injury in mice by activating hepatic interleukin-6 signaling through inter-organ crosstalk
- NAPQI is absent in the mouse brain after sub-hepatotoxic and hepatotoxic doses of acetaminophen
- Hepatic pyruvate and alanine metabolism are critical and complementary for maintenance of antioxidant capacity and resistance to oxidative insult in mice
Showing 5 of 6 shared publications
- Hepatic pyruvate and alanine metabolism are critical and complementary for maintenance of antioxidant capacity and resistance to oxidative insult
- Short‐Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis
- Exogenous phosphatidic acid reduces acetaminophen-induced liver injury in mice by activating hepatic interleukin-6 signaling through inter-organ crosstalk
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- NAPQI is absent in the mouse brain after sub-hepatotoxic and hepatotoxic doses of acetaminophen
Showing 5 of 6 shared publications
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Modifying laboratory testing via home brew during the COVID-19 pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas University
- Perceived Barriers to COVID-19 Testing
- Arkansans’ Preferred COVID-19 Testing Locations
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Rural Research Network to engage rural and minority community members in translational research
- Vaccine hesitancy or hesitancies? A latent class analysis of pediatric patients' parents
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Modifying laboratory testing via home brew during the COVID-19 pandemic
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas University
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas University
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas University
Similar Researchers
Based on overlapping research topics